{"id":2236,"date":"2017-07-18T08:26:54","date_gmt":"2017-07-18T12:26:54","guid":{"rendered":"https:\/\/www.stockcalc.com\/blog\/BrianD\/?p=2236"},"modified":"2017-07-18T08:26:54","modified_gmt":"2017-07-18T12:26:54","slug":"infinity-pharmaceuticals-infinas-and-orexigen-therapeutics-orexnas-trading-at-less-than-cash-value","status":"publish","type":"post","link":"https:\/\/www.stockcalc.com\/blog\/BrianD\/2017\/07\/18\/infinity-pharmaceuticals-infinas-and-orexigen-therapeutics-orexnas-trading-at-less-than-cash-value\/","title":{"rendered":"Infinity Pharmaceuticals (INFI:NAS) and Orexigen Therapeutics (OREX:NAS) Trading at Less than Cash Value"},"content":{"rendered":"

Stockcalc – Free Trial<\/h4>\n

Have a free look inside the StockCalc website at www.stockcalc.com<\/a><\/p>\n

\n
\n<\/hr>\n

I have used the analysis tools on the website stockcalc.com<\/a> to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/TopPicks.aspx<\/a>.<\/p>\n

Trading at Less than Cash Value<\/h4>\n

Today we are looking at companies trading at less than cash value<\/strong> meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.<\/p>\n

What this Means…<\/h5>\n

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P\/E greater than 0 and are worth exploring in more detail.<\/p>\n

Today’s Data on NASDAQ<\/h4>\n

Today’s data is for companies listed on the NASDAQ<\/strong>.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nClose Price<\/th>\nShares Outstanding<\/th>\nP\/E<\/th>\nP\/B<\/th>\nCash per Share<\/th>\nNet Cash per Share<\/th>\n<\/tr>\n
XNET<\/td>\nXunlei Ltd<\/td>\n3.220000<\/td>\n66183450<\/td>\nNone<\/td>\n0.5273<\/td>\n3.69<\/td>\nNone<\/td>\n<\/tr>\n
MLNK<\/td>\nModusLink Global Solutions Inc<\/td>\n1.670000<\/td>\n55554589<\/td>\nNone<\/td>\n1.3460<\/td>\n2.02<\/td>\n0.96<\/td>\n<\/tr>\n
CXRX<\/td>\nConcordia International Corp<\/td>\n1.620000<\/td>\n51089782<\/td>\nNone<\/td>\nNone<\/td>\n6.58<\/td>\n-62.94<\/td>\n<\/tr>\n
GURE<\/td>\nGulf Resources Inc<\/td>\n1.610000<\/td>\n46793791<\/td>\n1.9877<\/td>\n0.2095<\/td>\n3.69<\/td>\n3.64<\/td>\n<\/tr>\n
INFI<\/td>\nInfinity Pharmaceuticals Inc<\/td>\n1.410000<\/td>\n50443128<\/td>\nNone<\/td>\n0.9639<\/td>\n1.50<\/td>\n1.11<\/td>\n<\/tr>\n
VLRX<\/td>\nValeritas Holdings Inc<\/td>\n7.000000<\/td>\n6842978<\/td>\n4.9645<\/td>\n1.6346<\/td>\n7.48<\/td>\n2.64<\/td>\n<\/tr>\n
OREX<\/td>\nOrexigen Therapeutics Inc<\/td>\n2.890000<\/td>\n15227802<\/td>\nNone<\/td>\n0.8756<\/td>\n5.03<\/td>\n-6.60<\/td>\n<\/tr>\n
APWC<\/td>\nAsia Pacific Wire & Cable Corp Ltd<\/td>\n3.025000<\/td>\n13819669<\/td>\n14.4048<\/td>\n0.3075<\/td>\n3.49<\/td>\n1.44<\/td>\n<\/tr>\n
EVK<\/td>\nEver-Glory International Group Inc<\/td>\n2.650000<\/td>\n14792836<\/td>\n4.8182<\/td>\n0.4647<\/td>\n4.06<\/td>\n1.89<\/td>\n<\/tr>\n
JRJC<\/td>\nChina Finance Online Co Ltd<\/td>\n1.510000<\/td>\n23619603<\/td>\n2.8118<\/td>\n0.4702<\/td>\n1.87<\/td>\n1.54<\/td>\n<\/tr>\n
PRPH<\/td>\nProPhase Labs Inc<\/td>\n2.090000<\/td>\n16159796<\/td>\n2.4302<\/td>\n0.6665<\/td>\n2.65<\/td>\n2.65<\/td>\n<\/tr>\n
ZAIS<\/td>\nZAIS Group Holdings Inc<\/td>\n2.300000<\/td>\n14680782<\/td>\nNone<\/td>\n0.8245<\/td>\n3.05<\/td>\n-23.63<\/td>\n<\/tr>\n
GIGM<\/td>\nGigaMedia Ltd<\/td>\n3.030000<\/td>\n11052235<\/td>\nNone<\/td>\n0.5655<\/td>\n5.91<\/td>\n5.67<\/td>\n<\/tr>\n
CATB<\/td>\nCatabasis Pharmaceuticals Inc<\/td>\n1.230000<\/td>\n22470062<\/td>\nNone<\/td>\n1.1538<\/td>\n1.41<\/td>\n1.20<\/td>\n<\/tr>\n
PRTO<\/td>\nProteon Therapeutics Inc<\/td>\n1.400000<\/td>\n17574371<\/td>\nNone<\/td>\n0.7456<\/td>\n1.94<\/td>\n3.92<\/td>\n<\/tr>\n
ABAC<\/td>\nAoxin Tianli Group Inc<\/td>\n2.659900<\/td>\n7983745<\/td>\n14.6667<\/td>\n0.2504<\/td>\n7.08<\/td>\n6.75<\/td>\n<\/tr>\n
ATEC<\/td>\nAlphatec Holdings Inc<\/td>\n1.730000<\/td>\n10857733<\/td>\nNone<\/td>\nNone<\/td>\n2.35<\/td>\n-1.58<\/td>\n<\/tr>\n
ANTH<\/td>\nAnthera Pharmaceuticals Inc<\/td>\n1.490000<\/td>\n10079798<\/td>\nNone<\/td>\n6.2946<\/td>\n2.05<\/td>\n0.26<\/td>\n<\/tr>\n
GLBR<\/td>\nGlobal Brokerage Inc<\/td>\n2.000000<\/td>\n6143305<\/td>\n0.9091<\/td>\nNone<\/td>\n85.35<\/td>\n58.77<\/td>\n<\/tr>\n
CREG<\/td>\nChina Recycling Energy Corp<\/td>\n1.340000<\/td>\n8310198<\/td>\n5.1538<\/td>\n0.0548<\/td>\n5.66<\/td>\n-0.20<\/td>\n<\/tr>\n
TEAR<\/td>\nTearLab Corp<\/td>\n1.650000<\/td>\n5735732<\/td>\nNone<\/td>\nNone<\/td>\n2.27<\/td>\n-2.42<\/td>\n<\/tr>\n
ROSG<\/td>\nRosetta Genomics Ltd<\/td>\n2.190000<\/td>\n2588086<\/td>\nNone<\/td>\n1.2832<\/td>\n2.38<\/td>\n0.91<\/td>\n<\/tr>\n
KBSF<\/td>\nKBS Fashion Group Ltd<\/td>\n2.860000<\/td>\n1772016<\/td>\nNone<\/td>\n0.0615<\/td>\n13.49<\/td>\n12.01<\/td>\n<\/tr>\n
MDGS<\/td>\nMedigus Ltd<\/td>\n2.326500<\/td>\n1992571<\/td>\nNone<\/td>\n1.2673<\/td>\n4.23<\/td>\nNone<\/td>\n<\/tr>\n
NURO<\/td>\nNeuroMetrix Inc<\/td>\n2.220000<\/td>\n1268465<\/td>\nNone<\/td>\n0.3586<\/td>\n5.44<\/td>\n7.25<\/td>\n<\/tr>\n<\/table>\n

Let’s look at a few companies…<\/h4>\n

Lets look at a couple of the companies on this list to get a better understanding of them.<\/p>\n

INFI:NAS Infinity Pharmaceuticals<\/h6>\n

http:\/\/www.infi.com<\/a>
\nInfinity Pharmaceuticals has 23 employees and is headquartered in United States.
\nInfinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing and delivering medicines to people with difficult-to-treat diseases.<\/p>\n

OREX:NAS Orexigen Therapeutics<\/h6>\n

http:\/\/www.orexigen.com<\/a>
\nOrexigen Therapeutics has 132 employees and is headquartered in United States.
\nOrexigen Therapeutics Inc is an emerging pharmaceutical company. The company is developing neuroscience drugs that will ultimately address obesity and weight related medical issues.<\/p>\n

Free Valuation<\/h4>\n

Run a valuation on any of the companies listed above at www.stockcalc.com\/valureport.aspx<\/a> or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports<\/a>.<\/p>\n

The content presented here is in part from the website stockcalc.com<\/a> and is provided on an as is<\/strong> or as available<\/strong> basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.<\/em><\/p>\n

<\/div>\n
\n

Wait! We want you to try StockCalc for<\/span><\/h2>\n

5 Free Days <\/h1>\n

Yes, I want to find out what my stocks are worth<\/span><\/a>
\n No, I don’t want to know the value of my stocks<\/span><\/a>\n <\/div>\n","protected":false},"excerpt":{"rendered":"

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/TopPicks.aspx. Trading at Less than Cash Value Today we are looking at … Continue reading Infinity Pharmaceuticals (INFI:NAS) and Orexigen Therapeutics (OREX:NAS) Trading at Less than Cash Value<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[37,915,1874,1573,1572,1913,1914,39,1771,1772,41,38,1621,1622],"class_list":["post-2236","post","type-post","status-publish","format-standard","hentry","category-stocks-trading-at-less-than-cash-value","tag-cash-per-share","tag-concordia-international","tag-cxrx","tag-gulf-resources","tag-gure","tag-infi","tag-infinity-pharmaceuticals","tag-market-cap","tag-mlnk","tag-moduslink-global-solns","tag-nasdaq","tag-share-price","tag-xnet","tag-xunlei"],"jetpack_featured_media_url":"","jetpack_likes_enabled":true,"jetpack-related-posts":[],"jetpack_shortlink":"https:\/\/wp.me\/p6Fvkg-A4","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/posts\/2236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/comments?post=2236"}],"version-history":[{"count":1,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/posts\/2236\/revisions"}],"predecessor-version":[{"id":2237,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/posts\/2236\/revisions\/2237"}],"wp:attachment":[{"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/media?parent=2236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/categories?post=2236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stockcalc.com\/blog\/BrianD\/wp-json\/wp\/v2\/tags?post=2236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}